Tapentadol PR for Pain Syndromes in Real Life Patients with Hematological Malignancy.

@article{Brunetti2016TapentadolPF,
  title={Tapentadol PR for Pain Syndromes in Real Life Patients with Hematological Malignancy.},
  author={Gregorio Antonio Brunetti and Giovanna Palumbo and Giacomo S Morano and Erminia Baldacci and Ida Carmosino and Giorgia Annechini and Romina Talone and Sara Kiflom and Giada Mastrogiacomo and Sara Grammatico and Marta Chisini and Adriana Alencar Ara{\'u}jo Costa and Andrea Tendas and Laura Scaramucci and M. -H. Giovannini and Pasquale Niscola and Maria Teresa Petrucci and Claudio Cartoni},
  journal={Cardiovascular & hematological agents in medicinal chemistry},
  year={2016},
  volume={14 1},
  pages={68-74}
}
BACKGROUND More than 50% of oncohematological patients suffer from pain syndrome, mostly originating from the bone, which often include nociceptive and neuropathic complaints. Tapentadol, a recently available treatment option for cancer pain, exerts a dual analgesic mechanisms (opioid and noradrenergic), allowing for a high clinical efficacy as well as for… CONTINUE READING